Hep C Patients & Advocate Writers Needed for CURE Hepatitis C Website
Cure Hepatitis C is recruiting writers among Hepatitis C patients and advocates for a new web site and journal focusing on the disease and it’s patients.
This CURE Hepatitis C launching in the next couple days. Here is more information about this exciting new opportunity:
About the contributor model:
The payment for each online contributor article is based on the web traffic it generates. For each 1,000 unique visitors who view the article, we’ll pay $100. Payment will be sent by check within 30 days of the end of each month based on the percent of 1,000 visitors generated (ie, an article that generates 750 unique visitors will result in payment of $75). An article must generate a minimum of 250 visits ($25 payment) before a payment is sent. Payment is cumulative—i.e. it will be $100 for each additional 1,000 visits that each of the articles generates for up to 2 years. We’re also encouraging our contributors to recruit their colleagues to sign up by offering contributors a 10% bonus based on the earnings of every article submitted by a new writer who was referred by that contributor.
About Cure Hepatitis C:
CURE Hepatitis C is a quarterly journal and daily news web site that seeks to increase awareness for hepatitis C by highlighting the personal stories of patients and the hope that new treatment options bring.
CURE Media Group, through its unique and award-winning products, has been a source of information and inspiration for patients and families on the cancer journey since 2002. CURE Media Group’s flagship product, CURE™ magazine, is the indispensable guide to every stage of the cancer experience. With nearly 1 million readers, CURE is the largest consumer magazine in the United States focused entirely on cancer, with broad distribution to cancer patients, cancer centers, and advocacy groups.
CURE magazine, launched in 2002 for cancer patients, survivors and caregivers, has become the largest consumer magazine in the United States focused entirely on cancer. With a circulation of 300,000 individual subscribers account for over 170,000 of that figure with the remainder going to cancer centers and advocacy groups around the country. Since its inception, CURE has expanded to reflect the entire cancer continuum, including supportive care issues and long-term and late effects.
In 2014, Michael J. Hennessy Associates’ Inc (MJH) acquired CURE MEDIA GROUP. In 2015, MJH launched CURE Hepatitis C to share the inspiring stories of patients who have overcome the virus and inspire change that may help eradicate the virus.
For more information, please contact Dean Stephan at dstephan3@optimum.net
Last Updated on December 17, 2017 by HepFree NYC
Tags: Freelance Hepatitis C
){kind=link}